The nation of Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (£272m) over five years due to the United States' insistence on confidential information.
This move came to light following a official document dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesman later clarified that the United States was demanding access to genetic material for research and commercial purposes but was not willing to share the benefits from any future vaccines.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued negotiations to secure a agreement agreeable to both sides so the nation's vital HIV programme can continue.
Broader Background
This rejection follows a similar case in neighbouring Kenya, where a court blocked a related health funding agreement following concerns were raised about the safety of citizens' health data.
After returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its spending was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and responsibility.
As per reports, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Put simply, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our population if a future disease outbreak arise."
National Interest and Global Health
He also said that the American exit from the global health body and its push of bilateral health agreements were disrupting frameworks already set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We are open to continued dialogue with our US partners on how future collaboration could be arranged in a way that respects the independence and dignity of each country."
Health Experts Response
A leading public health body said it acknowledged the government's concerns, but urged that talks must proceed given that much of the country's HIV programmes depended on foreign aid.
"In cases where specific concerns exist, such as those relating to data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group said.
The halted deal highlights the complex debate between receiving much-needed international aid and safeguarding local interests in an ever more interconnected world.